PLAIN ENGLISH GROWTH CAPITAL LOAN AND SECURITY AGREEMENTLoan and Security Agreement • February 21st, 2008 • Bayhill Therapeutics, Inc. • Pharmaceutical preparations
This is a PLAIN ENGLISH GROWTH CAPITAL LOAN AND SECURITY AGREEMENT dated as of March 7, 2007 by and between BAYHILL THERAPEUTICS, INC., a Delaware corporation, and TRIPLEPOINT CAPITAL LLC, a Delaware company. The words “We”, “Us”, or “Our” refer to the Lender, which is TRIPLEPOINT CAPITAL LLC.
CONSULTING AGREEMENT TOLERION, INC.Consulting Agreement • February 21st, 2008 • Bayhill Therapeutics, Inc. • Pharmaceutical preparations • California
This Consulting Agreement (“Agreement”) is made as of April 16, 2002 (“Effective Date”) by and between Tolerion, Inc. (the “Company”) and Paul J. Utz, M.D. (the “Consultant”). The Consultant has been involved in scientific research in fields of particular interest to the Company. The Company wishes to retain the Consultant in a consulting capacity as a founding member of the Company’s Scientific Advisory Board, and as a consultant on scientific and medical matters for the Company, and the Consultant desires to perform such consulting services. Accordingly, the parties agree as follows:
FIRST AMENDMENT TO PLAIN ENGLISH GROWTH CAPITAL LOAN AND SECURITY AGREEMENTCapital Loan and Agreement • February 21st, 2008 • Bayhill Therapeutics, Inc. • Pharmaceutical preparations • California
This is a FIRST AMENDMENT TO PLAIN ENGLISH GROWTH CAPITAL LOAN AND AGREEMENT dated as of August 15, 2007 (the “Amendment”) by and between BAYHILL THERAPEUTICS, INC., (“Borrower”) and TRIPLEPOINT CAPITAL LLC, a Delaware limited liability company, (“Lender”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 21st, 2008 • Bayhill Therapeutics, Inc. • Pharmaceutical preparations
This Employment Agreement is made and entered into by and between Tolerion, Inc. (the “Company”) and Hideki Garren (the “Employee”), as of April 16, 2002.
